Usana Health Sciences (NYSE: USNA) insider transactions

In the twelve months to 10 November 2026, executives and directors of Usana Health Sciences reported 14 open-market sales of 46,163 shares ($894,831) and 0 open-market purchases, by 8 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Usana Health Sciences shares reported on Form 4
Date	Insider	Role	Transaction	Shares	Price	Held after	Filing
22 October 2026	Fuller Gilbert A	Director	Option exercise	+1,632	—	3,264	Form 4
22 October 2026	Wood Timothy E	Director	Option exercise	+1,632	—	13,469	Form 4
22 October 2026	Wood Timothy E	Director	Shares withheld for tax	−408	$14.52	13,061	Form 4
22 October 2026	Winssinger Frederic J	Director	Option exercise	+1,632	—	11,365	Form 4
22 October 2026	Nixon J Scott	Director	Option exercise	+1,632	—	13,077	Form 4
22 October 2026	Pelosi Peggie	Director	Option exercise	+1,632	—	7,693	Form 4
22 October 2026	Pelosi Peggie	Director	Shares withheld for tax	−935	$14.52	6,758	Form 4
22 October 2026	Fleming John Turman	Director	Option exercise	+1,632	—	7,494	Form 4
22 October 2026	Ding Xia	Director	Option exercise	+1,632	—	9,910	Form 4
22 October 2026	Ding Xia	Director	Shares withheld for tax	−604	$14.52	9,306	Form 4
25 July 2026	Benedict Peter	Chief Information Officer	Option exercise	+598	—	598	Form 4
25 July 2026	Benedict Peter	Chief Information Officer	Shares withheld for tax	−176	$21.32	422	Form 4
25 July 2026	Armstrong Kathryn Michelle	Chief Scientific Officer	Option exercise	+1,166	—	3,989	Form 4
25 July 2026	Armstrong Kathryn Michelle	Chief Scientific Officer	Shares withheld for tax	−518	$21.32	3,471	Form 4
23 July 2026	Fuller Gilbert A	Director	Option exercise	+1,632	—	1,632	Form 4
23 July 2026	Wood Timothy E	Director	Option exercise	+1,632	—	12,245	Form 4
23 July 2026	Wood Timothy E	Director	Shares withheld for tax	−408	$20.92	11,837	Form 4
23 July 2026	Winssinger Frederic J	Director	Option exercise	+1,632	—	9,733	Form 4
23 July 2026	Nixon J Scott	Director	Option exercise	+1,632	—	11,445	Form 4
23 July 2026	Pelosi Peggie	Director	Option exercise	+1,632	—	6,996	Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Usana Health Sciences page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.